Accuray receives 510(k) fda clearance for clearrt™ helical kvct imaging for the radixact® treatment delivery system

Sunnyvale, calif., jan. 5, 2021 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today that the company has received 510(k) clearance from the u.s. food and drug administration (fda) for its clearrt™ helical kvct imaging* for the radixact® system, the next generation...
ARAY Ratings Summary
ARAY Quant Ranking